13 results on '"Elders P"'
Search Results
2. A randomized controlled trial to assess if changing sleep timing can improve glucose metabolism in people with prediabetes and type 2 diabetes
- Author
-
Bouman, Emma J., Slebe, Romy, Stenvers, Dirk Jan, Elders, Petra J. M., Beulens, Joline W. J., and Rutters, Femke
- Published
- 2024
- Full Text
- View/download PDF
3. A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study: study protocol for a randomised controlled trial
- Author
-
Langendoen-Gort, Marlous, Al-Jabr, Hiyam, Hugtenburg, Jacqueline G., Rutters, Femke, de Wit, Maartje, Bhattacharya, Debi, Abu-Hanna, Ameen, Farmer, Andrew, and Elders, Petra J. M.
- Published
- 2022
- Full Text
- View/download PDF
4. Effectiveness and cost-effectiveness of text messages with or without endowment incentives for weight management in men with obesity (Game of Stones): study protocol for a randomised controlled trial
- Author
-
Macaulay, Lisa, O’Dolan, Catriona, Avenell, Alison, Carroll, Paula, Cotton, Seonaidh, Dombrowski, Stephan, Elders, Andrew, Goulao, Beatriz, Gray, Cindy, Harris, Fiona M., Hunt, Kate, Kee, Frank, MacLennan, Graeme, McDonald, Matthew David, McKinley, Michelle, Skinner, Rebecca, Torrens, Claire, Tod, Martin, Turner, Katrina, van der Pol, Marjon, and Hoddinott, Pat
- Published
- 2022
- Full Text
- View/download PDF
5. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial
- Author
-
Hagen, Suzanne, Kearney, Rohna, Goodman, Kirsteen, Melone, Lynn, Elders, Andrew, Manoukian, Sarkis, Agur, Wael, Best, Catherine, Breeman, Suzanne, Dembinsky, Melanie, Dwyer, Lucy, Forrest, Mark, Graham, Margaret, Guerrero, Karen, Hemming, Christine, Khunda, Aethele, Mason, Helen, McClurg, Doreen, Norrie, John, Karachalia-Sandri, Anastasia, Thakar, Ranee, and Bugge, Carol
- Published
- 2020
- Full Text
- View/download PDF
6. The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluation
- Author
-
Bugge, Carol, Kearney, Rohna, Dembinsky, Melanie, Khunda, Aethele, Graham, Margaret, Agur, Wael, Breeman, Suzanne, Dwyer, Lucy, Elders, Andrew, Forrest, Mark, Goodman, Kirsteen, Guerrero, Karen, Hemming, Christine, Mason, Helen, McClurg, Doreen, Melone, Lynn, Norrie, John, Thakar, Ranee, and Hagen, Suzanne
- Published
- 2020
- Full Text
- View/download PDF
7. A systematic review of the use of an expertise-based randomised trial design
- Author
-
Cook, Jonathan, Elders, Andrew, Boachie, Charles, Bassigna, Ted, Fraser, Cynthia, Altman, Doug, Boutron, Isabelle, Ramsay, Craig, and Maclennan, Graeme
- Published
- 2015
- Full Text
- View/download PDF
8. A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial
- Author
-
Charlotte Andriessen, Marieke T. Blom, Beryl A. C. E. van Hoek, Anna W. de Boer, Petra Denig, G. Ardine de Wit, Karin Swart, Angela de Rooij-Peek, Rob J. van Marum, Jacqueline G. Hugtenburg, Pauline Slottje, Daniël van Raalte, Liselotte van Bloemendaal, Ron Herings, Giel Nijpels, Rimke C. Vos, and Petra J. M. Elders
- Subjects
Elderly ,Type 2 diabetes ,Overtreatment ,Hypoglycaemia ,General practitioners ,Extended normalisation process theory ,Medicine (General) ,R5-920 - Abstract
Abstract Background Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication in older patients. However, evidence is lacking that a medication reduction in older patients can be safely pursued. Here, we will examine if promoting the deprescribing of insulin/sulphonylureas with a deprescribing programme (DPP) in general practice affects T2D-complications in older overtreated patients. Methods We will perform a 1:1 cluster randomised controlled trial in 86 general practices in the Netherlands. The DPP will consist of education sessions with general practitioners and practice nurses about reducing glucose-lowering medication in older patients (≥ 70 years). Topics of the sessions include the necessity of deprescribing, tools to initiate deprescribing and strategies to discuss deprescribing with patients (shared decision making). The DPP further includes a support programme with practice visits. The study will employ a selection tool to identify possibly overtreated older patients from the electronic medical records of the general practitioner. Eligibility for enrolment in the study will be based on HbA1c targets indicated by the Dutch guidelines, which depend on age, diabetes duration, presence of frailty, and life expectancy. The control group will provide usual care. We aim to include 406 patients. The follow-up period will be 2 years. For the primary outcome, the effect of the DPP on T2D-complications will be assessed by counting the cumulative incidence of events related to under- and overtreatment in T2D as registered in the electronic medical records. We shall perform an intention-to-treat analysis and an analysis including only patients for whom deprescribing was initiated. The implementation of the DPP in general practice will be evaluated quantitatively and qualitatively using the Extended Normalisation Process Theory (ENPT) and the Reach, Efficacy – Adoption, Implementation and Maintenance (RE-AIM) model. Other secondary outcomes include quality of life, cognitive functioning, events related to overtreatment or undertreatment, biomarkers of health, amount of blood glucose-lowering medication prescriptions, and cost-effectiveness. Discussion This study will provide insight into the safety and feasibility of a programme aimed at deprescribing sulphonylureas/insulin in older people with T2D who are treated in general practice. Trial registration ISRCTN Registry, ISRCTN50008265 , registered 09 March, 2023.
- Published
- 2024
- Full Text
- View/download PDF
9. A randomized controlled trial to assess if changing sleep timing can improve glucose metabolism in people with prediabetes and type 2 diabetes
- Author
-
Emma J. Bouman, Romy Slebe, Dirk Jan Stenvers, Petra J. M. Elders, Joline W. J. Beulens, and Femke Rutters
- Subjects
Social jetlag ,Circadian rhythm ,Type 2 diabetes mellitus ,Glycemic control ,Metabolic control ,Randomized controlled trial ,Medicine (General) ,R5-920 - Abstract
Abstract Background Social jetlag is a chronic disruption of sleep timing that is characterized by different sleep timing during workdays and free days. Social jetlag has been associated with disturbed glucose metabolism, insulin resistance, and increased risk of metabolic syndrome and type 2 diabetes. In this study, we aim to investigate whether a combination of bright light therapy in the morning, bright light reduction in the evening and sleep advance instructions for 3 weeks reduces social jetlag and if this results in improvement of glycemic and metabolic control, sleep, mood and quality of life after 3 and 12 weeks in people with prediabetes and type 2 diabetes and to assess possible mediators, compared to regular sleep habits. Methods In this randomized controlled trial, 60 people with prediabetes or type 2 diabetes with > 1 h social jetlag will be recruited. The intervention consists of bright light therapy (5000 lx) emitted by Vitamine-L (Lumie, UK) for 30 min each morning, combined with the advice to follow sleep advance instructions and to wear bright light-dimming goggles every evening for a period of 3 weeks. The control group adheres to their regular sleep habits and conditions. The primary outcome is glycated hemoglobin (HbA1c) after 12 weeks comparing the intervention and control in an intention-to-treat analysis. Secondary outcomes at 3 and 12 weeks are (1) social jetlag; (2) insulin sensitivity, fasting blood glucose, glucose-lowering medication use, and frequency of perceived hypoglycemia; (3) metabolic outcomes, including body mass index (BMI), waist circumference, body fat percentage, and blood pressure; (4) mood, including depression, fatigue and anxiety (measured with questionnaires); and (5) quality of life measured using EQ5D questionnaire. To assess other factors that might play a role as possible mediators, we will measure (para)sympathetic nervous system activity assessed with ECGs and electrochemical skin conductance tests, sleep quality and sleep phase distribution assessed with a sleep measuring headband (ZMax), the Dim Light Melatonin Onset in saliva samples (in a subgroup) at 3 and 12 weeks, the feeling of satiety and satiation with a 10-cm visual analog scale (VAS), diet using a food frequency questionnaire, and physical activity using an accelerometer (ActiGraph). Discussion Social jetlag can contribute to poorer glycemic control and metabolic control in those with type 2 diabetes. With this intervention, we aim to reduce social jetlag and thereby improve glycemic and metabolic control. This could offer a way to improve overall population health and to reduce the disease burden of type 2 diabetes. Trial registration ISRCTN registry ISRCTN11967109 . Registered on 9 May 2024.
- Published
- 2024
- Full Text
- View/download PDF
10. A personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with type 2 diabetes mellitus, the INTENSE study: study protocol for a randomised controlled trial
- Author
-
Marlous Langendoen-Gort, Hiyam Al-Jabr, Jacqueline G. Hugtenburg, Femke Rutters, Maartje de Wit, Debi Bhattacharya, Ameen Abu-Hanna, Andrew Farmer, and Petra J. M. Elders
- Subjects
Type 2 diabetes mellitus ,Medication adherence ,Personalised intervention programme ,Pharmacy ,Medicine (General) ,R5-920 - Abstract
Abstract Background Medication non-adherence is a prevalent health problem in people with type 2 diabetes mellitus (T2DM). Interventions have previously been developed to improve medication adherence, but inconsistent outcomes have been reported. A potential explanation for this inconsistency is a ‘one size fits all’ approach, with interventions not tailored to the needs and preferences of individuals. Therefore, the aim of this study is to evaluate the effectiveness of a personalised intervention programme aimed at improving adherence to oral antidiabetic and/or antihypertensive medication in people with T2DM. Methods A parallel-group randomised controlled trial will be conducted in 40–50 community pharmacies in the Netherlands and the United Kingdom (UK). A total of 300 participants will be included and followed up for a period of 6 months. Participants will be people with T2DM identified as non-adherent to oral antidiabetic and/or antihypertensive medication, aged 35–75 years and mobile phone users. The intervention group will receive a personalised intervention programme that is based on one or more of the participants’ pre-defined non-adherence profile(s), namely (I) Knowledge and perceptions, (II) Practical problems, (III) Side effects and (IV) Negative mood and beliefs. The intervention comprises of one or more supporting modules, namely (I) Brief messaging, (II) Clinical medication review, (III) Medication schedule, (IV) Reminding messaging, (V) Medication dispensing systems, (VI) Smart messaging, (VII) Referral to general practitioner and (VIII) Unguided web-based Self Help Application for low mood. The control group will receive usual care including access to a publicly available informative diabetes website. The primary study outcome is medication adherence measured with a telephone pill count. Secondary outcomes are systolic blood pressure, HbA1c level, self-reported medication adherence, attitude and beliefs toward medication, satisfaction with diabetes treatment, health status and medical consumption and productivity cost. In addition, a process evaluation will be undertaken to establish the fidelity, reach and the extent to which intervention delivery is normalised in the daily practice of community pharmacy teams. Discussion The study can lead to a personalised intervention programme that improves medication adherence in people with T2DM that are non-adherent to oral antidiabetic and/or antihypertensive medication. Trial registration Dutch Trial Register, Trial NL8747 , registered 02 July, 2020; ISRCTN Registry, ISRCTN36009809 , registered 05 February, 2020.
- Published
- 2022
- Full Text
- View/download PDF
11. Effectiveness and cost-effectiveness of text messages with or without endowment incentives for weight management in men with obesity (Game of Stones): study protocol for a randomised controlled trial
- Author
-
Lisa Macaulay, Catriona O’Dolan, Alison Avenell, Paula Carroll, Seonaidh Cotton, Stephan Dombrowski, Andrew Elders, Beatriz Goulao, Cindy Gray, Fiona M. Harris, Kate Hunt, Frank Kee, Graeme MacLennan, Matthew David McDonald, Michelle McKinley, Rebecca Skinner, Claire Torrens, Martin Tod, Katrina Turner, Marjon van der Pol, and Pat Hoddinott
- Subjects
Randomised controlled trial ,Men with obesity ,Text messages ,Financial incentives ,Weight management ,Health inequalities ,Medicine (General) ,R5-920 - Abstract
Abstract Background Obesity increases the risk of type 2 diabetes, heart disease, stroke, mobility problems and some cancers, and its prevalence is rising. Men engage less than women in existing weight loss interventions. Game of Stones builds on a successful feasibility study and aims to find out if automated text messages with or without endowment incentives are effective and cost-effective for weight loss at 12 months compared to a waiting list comparator arm in men with obesity. Methods A 3-arm, parallel group, assessor-blind superiority randomised controlled trial with process evaluation will recruit 585 adult men with body mass index of 30 kg/m2 or more living in and around three UK centres (Belfast, Bristol, Glasgow), purposively targeting disadvantaged areas. Intervention groups: (i) automated, theory-informed text messages daily for 12 months plus endowment incentives linked to verified weight loss targets at 3, 6 and 12 months; (ii) the same text messages and weight loss assessment protocol; (iii) comparator group: 12 month waiting list, then text messages for 3 months. The primary outcome is percentage weight change at 12 months from baseline. Secondary outcomes at 12 months are as follows: quality of life, wellbeing, mental health, weight stigma, behaviours, satisfaction and confidence. Follow-up includes weight at 24 months. A health economic evaluation will measure cost-effectiveness over the trial and over modelled lifetime: including health service resource-use and quality-adjusted life years. The cost-utility analysis will report incremental cost per quality-adjusted life years gained. Participant and service provider perspectives will be explored via telephone interviews, and exploratory mixed methods process evaluation analyses will focus on mental health, multiple long-term conditions, health inequalities and implementation strategies. Discussion The trial will report whether text messages (with and without cash incentives) can help men to lose weight over 1 year and maintain this for another year compared to a comparator group; the costs and benefits to the health service; and men’s experiences of the interventions. Process analyses with public involvement and service commissioner input will ensure that this open-source digital self-care intervention could be sustainable and scalable by a range of NHS or public services. Trial registration ISRCTN 91974895 . Registered on 14/04/2021.
- Published
- 2022
- Full Text
- View/download PDF
12. The TOPSY pessary self-management intervention for pelvic organ prolapse: a study protocol for the process evaluation
- Author
-
Carol Bugge, Rohna Kearney, Melanie Dembinsky, Aethele Khunda, Margaret Graham, Wael Agur, Suzanne Breeman, Lucy Dwyer, Andrew Elders, Mark Forrest, Kirsteen Goodman, Karen Guerrero, Christine Hemming, Helen Mason, Doreen McClurg, Lynn Melone, John Norrie, Ranee Thakar, and Suzanne Hagen
- Subjects
Process evaluation ,Prolapse ,Pessary ,Self-management ,Randomised controlled trial ,Medicine (General) ,R5-920 - Abstract
Abstract Background Process evaluations have become a valued component, alongside clinical trials, of the wider evaluation of complex health interventions. They support understanding of implementation, and fidelity, related to the intervention and provide valuable insights into what is effective in a practical setting by examining the context in which interventions are implemented. The TOPSY study consists of a large multi-centre randomised controlled trial comparing the effectiveness of pessary self-management with clinic-based care in improving women’s condition-specific quality of life, and a nested process evaluation. The process evaluation aims to examine and maximise recruitment to the trial, describe intervention fidelity and explore participants’ and healthcare professionals’ experiences. Methods The trial will recruit 330 women from approximately 17 UK centres. The process evaluation uses a mixed-methods approach. Semi-structured interviews will be conducted with randomised women (18 per randomised group/n = 36), women who declined trial participation but agreed to interview (non-randomised women) (n = 20) and healthcare professionals recruiting to the trial (n ~ 17) and delivering self-management and clinic-based care (n ~ 17). The six internal pilot centres will be asked to record two to three recruitment discussions each (total n = 12–18). All participating centres will be asked to record one or two self-management teaching appointments (n = 30) and self-management 2-week follow-up telephone calls (n = 30). Process data (quantitative and qualitative) will be gathered in participant completed trial questionnaires. Interviews will be analysed thematically and recordings using an analytic grid to identify fidelity to the intervention. Quantitative analysis will be predefined within the process evaluation analysis plan. Discussion The wide variety of pessary care delivered across the UK for women with pelvic organ prolapse presents specific localised contexts in which the TOPSY interventions will be implemented. Understanding this contextual variance is central to understanding how and in what circumstances pessary self-management can be implemented (should it be effective). The inclusion of non-randomised women provides an innovative way of collecting indispensable information about eligible women who decline trial participation, allowing broader contextualisation and considerations of generalisability of trial findings. Methodological insights from examination of recruitment processes and mechanisms have the potential to inform recruitment mechanisms and future recruitment strategies and study designs. Trial registration ISRCTN62510577 . Registered on 6 October 2017.
- Published
- 2020
- Full Text
- View/download PDF
13. Clinical and cost-effectiveness of vaginal pessary self-management compared to clinic-based care for pelvic organ prolapse: protocol for the TOPSY randomised controlled trial
- Author
-
Suzanne Hagen, Rohna Kearney, Kirsteen Goodman, Lynn Melone, Andrew Elders, Sarkis Manoukian, Wael Agur, Catherine Best, Suzanne Breeman, Melanie Dembinsky, Lucy Dwyer, Mark Forrest, Margaret Graham, Karen Guerrero, Christine Hemming, Aethele Khunda, Helen Mason, Doreen McClurg, John Norrie, Anastasia Karachalia-Sandri, Ranee Thakar, and Carol Bugge
- Subjects
Prolapse ,Pessary ,Self-management ,Quality of life ,Economic evaluation ,Randomised controlled trial (RCT) ,Medicine (General) ,R5-920 - Abstract
Abstract Background Pelvic organ prolapse (or prolapse) is a common condition in women where the pelvic organs (bladder, bowel or womb) descend into the vagina and cause distressing symptoms that adversely affect quality of life. Many women will use a vaginal pessary to treat their prolapse symptoms. Clinic-based care usually consists of having a pessary fitted in a primary or secondary care setting, and returning approximately every 6 months for healthcare professional review and pessary change. However, it is possible that women could remove, clean and re-insert their pessary themselves; this is called self-management. This trial aims to assess if self-management of a vaginal pessary is associated with better quality of life for women with prolapse when compared to clinic-based care. Methods This is a multicentre randomised controlled trial in at least 17 UK centres. The intervention group will receive pessary self-management teaching, a self-management information leaflet, a follow-up phone call and access to a local telephone number for clinical support. The control group will receive the clinic-based pessary care which is standard at their centre. Demographic and medical history data will be collected from both groups at baseline. The primary outcome is condition-specific quality of life at 18 months’ post-randomisation. Several secondary outcomes will also be assessed using participant-completed questionnaires. Questionnaires will be administered at baseline, 6, 12 and 18 months’ post-randomisation. An economic evaluation will be carried out alongside the trial to evaluate cost-effectiveness. A process evaluation will run parallel to the trial, the protocol for which is reported in a companion paper. Discussion The results of the trial will provide robust evidence of the effectiveness of pessary self-management compared to clinic-based care in terms of improving women’s quality of life, and of its cost-effectiveness. Trial registration ISRCTN Registry ISRCTN62510577 . Registered on June 10, 2017.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.